• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

New Technologies/Methodologies to Assess Chemical Food Safety

Description: CFSAN scientists are developing/using established medium throughput biomarker assays and in vivo model systems to assess the safety of food and dietary supplement ingredient/contaminants and to assess the ability of the in vitro systems to predict toxicity (predictive modeling) in vivo. It is our hope that the identification and verification, of medium throughput screening methods via in vivo testing will improve toxicity characterization, increase efficiency, reduce cost as well as refine, reduce or replace animal use.

Briefing Status: ON TRACK

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Findings of the in vitro assays will be compared with the in vivo systems to assess the ability of the in vitro systems to predict toxicity in vivo
i. Comparison of in vitro renal toxicity results with in vivo results and assessment of the ability of the in vitro renal toxicity test system to predict toxicity in vivo 6/1/2017
Completed 6/1/2017
ii. Comparison of in vitro cardiotoxicity results with in vivo results and assessment of the ability of the in vitro cardiotoxicity test system to predict toxicity in vivo 6/1/2017
Completed 6/1/2017
iii. Provide all results to the Program Office 7/1/2018
On Hold

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-